Combining Heavy-Ion Therapy with Immunotherapy: An Update on Recent Developments
Open Access
- 1 June 2018
- journal article
- research article
- Published by Elsevier in International Journal of Particle Therapy
- Vol. 5 (1) , 84-93
Abstract
Clinical trials and case reports of cancer therapies combining radiation therapy with immunotherapy have at times demonstrated total reduction or elimination of metastatic disease. While virtually all trials focus on the use of immunotherapy combined with conventional photon irradiation, the dose-distributive benefits of particles, in particular the distinct biological effects of heavy ions, have unknown potential vis-a-vis systemic disease response. Here, we review recent developments and evidence with a focus on the potential for heavy-ion combination therapy.Keywords
This publication has 86 references indexed in Scilit:
- p53-independent early and late apoptosis is mediated by ceramide after exposure of tumor cells to photon or carbon ion irradiationBMC Cancer, 2013
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm ShiftJNCI: Journal of the National Cancer Institute, 2013
- Immunologic Correlates of the Abscopal Effect in a Patient with MelanomaNew England Journal of Medicine, 2012
- DNA breaks and chromosome pulverization from errors in mitosisNature, 2012
- γ-Radiation Promotes Immunological Recognition of Cancer Cells through Increased Expression of Cancer-Testis Antigens In Vitro and In VivoPLOS ONE, 2011
- Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cellsJournal of Experimental Medicine, 2011
- Type I interferon is selectively required by dendritic cells for immune rejection of tumorsJournal of Experimental Medicine, 2011
- The ATM–p53 pathway suppresses aneuploidy-induced tumorigenesisProceedings of the National Academy of Sciences, 2010
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signallingNature, 2008
- Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapyJournal of Experimental Medicine, 2006